Screening for Chlamydia trachomatis Infections in Women

N Engl J Med. 2017 Feb 23;376(8):765-773. doi: 10.1056/NEJMcp1412935.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Azithromycin / therapeutic use
  • Chlamydia Infections / complications
  • Chlamydia Infections / diagnosis*
  • Chlamydia Infections / drug therapy
  • Chlamydia trachomatis*
  • Cost-Benefit Analysis
  • Doxycycline / therapeutic use
  • Female
  • Humans
  • Mass Screening / economics
  • Mass Screening / methods
  • Pelvic Inflammatory Disease / etiology
  • Practice Guidelines as Topic
  • Pregnancy
  • Pregnancy Complications, Infectious / diagnosis
  • Pregnancy, Ectopic / etiology
  • Risk Factors
  • Self Care
  • Sexual Behavior
  • Young Adult

Substances

  • Anti-Bacterial Agents
  • Azithromycin
  • Doxycycline

Associated data

  • ClinicalTrials.gov/NCT00907361